Report Detail
Blood Collection, Processing, Management Devices & Consumables Global Market
- RnM2895572 |
- 12 March, 2020 |
- Global |
- 441 Pages |
- IQ4I Research & Consultancy |
- Medical Devices & Consumables
Blood collection, processing, management devices & consumables are class of medical devices used for collecting the whole blood from the donor, segregating the collected blood into blood components like RBC, WBC, platelets & plasma and then preserving the segregated components for the purpose of therapeutics and maintaining the protocols of available blood groups and donor information for serving the emergency purposes. These devices are mainly used for therapeutic and diagnostic medical applicational areas, where in therapeutic application the processed blood act as a lifesaving liquid organ. These blood collection, processing, management devices & consumables help in avoiding the transmission of infectious diseases and other complications during transfusion.
Blood collection, processing, management devices & consumables market is segmented on the basis of applications, products, end-users and geography. In blood collection, processing, management devices & consumables market, applications market is further classified into diagnostics, therapeutics, research and others (transplantation compatibility tests and therapeutic drug effect monitoring), whereas diagnostics application market is further sub classified into infectious disease diagnosis, non infectious disease diagnosis, blood typing and others (doping, forensics and pregnancy tests), therapeutic applications are further segmented into hematology diseases, injury, trauma & surgeries and oncology. Products market is segmented into by devices, consumables, softwares and servicing, whereas devices are further classified into hematocrit centrifuges, blood grouping analyzers, blood coagulation analyzers, hematology analyzers, blood processors, blood warmers, blood bank refrigerators, blood bank freezers, slide stainer others. Consumables are subsegmented into blood administration sets, blood collection needles & syringes, blood collection tubes & microcollectors, blood lancets, blood filters, hematology reagents, blood bags, microscopic slides, vials, sedimentation tubes, blood grouping reagents, blood coagulation reagents, blood bags, blood filters, sedimentation tubes, hematology reagents, vials and others. By softwares are further segmented into hospital softwares and blood bank softwares. End-users are further classified into hospitals, diagnostic laboratories, academic & research laboratories, blood & blood component banks, ambulatory surgical center and others (biopharma & biotech companies and clinics).
Among the blood collection, processing, management devices & consumables product market, consumables segment holds the largest share and is expected to be the fastest growing segment from 2016 to 2023. In end-users, Hospitals are the largest segment and is the fastest growing segment from 2016 to 2023. Geographically, North America is the largest market followed by Europe and Asia Pacific. The APAC region is the fastest growing region from 2016 to 2023 presenting an array of opportunities for growth and is likely to get attention of new investors in the blood collection, processing, management devices & consumables market. Growth in the Asian market is attributed to rising prevalence of lifestyle diseases and government initiatives in establishing innovative technologies and demand for sophisticated medical services.
The blood collection, processing, management devices & consumables market is expected to grow at a mid range single digit CAGR to reach $35,693 million by 2023. Increase in aging population and subsequent rise in incidence of chronic diseases, emergence of advanced automated blood collection and processing devices and favourable reimbursement policies are the factors driving the market growth. Emergence of needle free devices & RFID technology and market expansion opportunities in emerging countries are some of the opportunities of this market.
However various factors like patient safety risks due to chances of transmission of infectious diseases and lack of skilled professionals in handling automated processing devices limit the growth of blood collection, processing, management devices & consumables global market. The threats for the blood collection, processing, management devices & consumables market include soaring costs of blood handling devices and stringent government regulatory bodies guiding blood processing devices & consumables manufacturers.
The blood collection, processing, management devices & consumables global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the Blood collection, processing, management devices & consumables market are Abbott Laboratories (U.S.), Becton Dickinson & Company (U.S.), Haemonetics Corporation (U.S.), Grifols International S.A. (Spain), Immucor, Inc. (U.S.), Danaher Corporation (U.S.), Fresenius Kabi (U.K.), Sysmex Corporation (Japan), Terumo Corporation (Japan), Macopharma (France), ThermoFisher Scientific Corporation (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions and their sub regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)
1 EXECUTIVE SUMMARY 35
2 INTRODUCTION 43
- 2.1 KEY TAKE AWAYS 43
- 2.2 REPORT DESCRIPTION 44
- 2.3 MARKETS COVERED 46
- 2.4 STAKEHOLDERS 48
- 2.5 RESEARCH METHODOLOGY 49
- 2.5.1 MARKET SIZE ESTIMATION 51
- 2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION 53
- 2.5.3 SECONDARY SOURCES 54
- 2.5.4 PRIMARY SOURCES 54
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 55
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 56
- 2.5.7 ASSUMPTIONS 56
3 MARKET ANALYSIS 58
- 3.1 INTRODUCTION 58
- 3.2 MARKET SEGMENTATION 59
- 3.3 FACTORS INFLUENCING MARKET 61
- 3.3.1 DRIVERS AND OPPORTUNITIES 62
- 3.3.1.1 Increase in aging population and subsequent rise in incidence of
chronic diseases 62
- 3.3.1.2 Emergence of advanced automated blood collection & processing devices 62
- 3.3.1.3 Favorable reimbursement policies 63
- 3.3.1.4 Emergence of needle free devices and RFID technology 64
- 3.3.1.5 Market expansion opportunities in emerging nations 64
- 3.3.1 DRIVERS AND OPPORTUNITIES 62
- 3.3.2 RESTRAINTS AND THREATS 65
- 3.3.2.1 Patient safety risks due to chances of transmission of infections and infectious diseases 65
- 3.3.2.2 Lack of skilled professionals in handling automated processing devices 66
- 3.3.2.3 Soaring cost of blood processing devices 67
- 3.3.2.4 Stringent regulatory bodies guiding the blood collection, processing,
management devices & consumables manufacturers 67
- 3.4 REGULATORY AFFAIRS 68
- 3.4.1 U.S. 68
- 3.4.2 EUROPE 69
- 3.4.3 INDIA 70
- 3.4.4 CHINA 70
- 3.4.5 JAPAN 71
- 3.5 REIMBURSEMENT SCENARIO 71
- 3.5.1 REIMBURSEMENT TABLE 72
- 3.6 TECHNOLOGICAL ADVANCEMENTS 76
- 3.6.1 AUTOMATED BLOOD COLLECTION & PROCESSING DEVICES 77
- 3.6.2 PORTABLE BLOOD COLLECTION & PROCESSING DEVICES 77
- 3.6.3 CUSTOMIZED BLOOD COLLECTION, PROCESSING DEVICES & CONSUMABLES 78
- 3.6.4 HEMOSEP 3-D PRINTED BLOOD COLLECTION DEVICES 78
- 3.6.5 MICROFLUIDIC BLOOD COLLECTION DEVICES 79
- 3.6.6 RFID (RADIOFREQUENCY IDENTIFICATION) TECHNOLOGY 79
- 3.6.7 ROBOTICS IN BLOOD COLLECTION & MANAGEMENT 80
- 3.7 MANUAL V/S AUTOMATED BLOOD COLLECTION AND PROCESSING DEVICES 81
- 3.8 SUPPLY CHAIN ANALYSIS 83
- 3.9 PORTER’S FIVE FORCE ANALYSIS 87
- 3.9.1 THREAT OF NEW ENTRANTS 88
- 3.9.2 THREAT OF SUBSTITUTES 89
- 3.9.3 RIVALRY AMONG EXISTING COMPETITORS 90
- 3.9.4 BARGAINING POWER OF SUPPLIERS 90
- 3.9.5 BARGAINING POWER OF BUYERS 91
- 3.10 MARKET SHARE ANALYSIS 92
4 BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET, BY PRODUCTS 95
- 4.1 INTRODUCTION 95
- 4.2 BY DEVICES 99
- 4.2.1 HEMATOCRIT CENTRIFUGE 104
- 4.2.2 BLOOD GROUPING ANALYZERS 107
- 4.2.3 BLOOD COAGULATION ANALYZERS 111
- 4.2.4 HEMATOLOGY ANALYZERS 113
- 4.2.5 BLOOD CELL PROCESSORS 116
- 4.2.6 BLOOD WARMERS 118
- 4.2.7 BLOOD BANK REFRIGERATORS 120
- 4.2.8 BLOOD BANK FREEZERS 123
- 4.2.9 SLIDE STAINERS 124
- 4.2.10 OTHERS 126
- 4.3 CONSUMABLES 133
- 4.3.1 BLOOD COLLECTION NEEDLE & SYRINGE 137
- 4.3.2 BLOOD COLLECTION TUBES & MICROCOLLECTORS 140
- 4.3.3 BLOOD LANCETS 143
- 4.3.4 BLOOD BAGS 145
- 4.3.5 BLOOD FILTERS 147
- 4.3.6 SEDIMENTATION TUBES 150
- 4.3.7 BLOOD COAGULATION REAGENTS 152
- 4.3.8 BLOOD GROUPING REAGENTS 154
- 4.3.9 HEMATOLOGY REAGENTS 156
- 4.3.10 BLOOD ADMINISTRATION SETS 158
- 4.3.11 BLOOD VIALS 160
- 4.3.12 OTHERS 162
- 4.4 MANAGEMENT SOFTWARES 166
- 4.4.1 BLOOD BANK SOFTWARES 170
- 4.4.2 HOSPITAL SOFTWARES 173
- 4.5 SERVICING 175
5 BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET, BY APPLICATION 177
- 5.1 INTRODUCTION 177
- 5.2 DIAGNOSTICS 180
- 5.2.1 INFECTIOUS DISEASE DIAGNOSIS 184
- 5.2.2 NON-INFECTIOUS DISEASE DIAGNOSIS 189
- 5.2.3 BLOOD TYPING 193
- 5.2.4 OTHERS 197
- 5.3 THERAPEUTICS 200
- 5.3.1 HAEMATOLOGY DISEASES 204
- 5.3.2 INJURY, TRAUMA & SURGERY 208
- 5.3.3 ONCOLOGY 211
- 5.4 RESEARCH 214
- 5.5 OTHERS 219
6 BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES GLOBAL MARKET, BY END-USERS 224
- 6.1 INTRODUCTION 224
- 6.2 HOSPITALS 227
- 6.3 ACADEMIC INSTITUTES & RESEARCH LABORATORIES 229
- 6.4 DIAGNOSTIC LABORATORIES 230
- 6.5 AMBULATORY SURGICAL CENTERS 232
- 6.6 BLOOD & BLOOD COMPONENT BANK 233
- 6.7 OTHERS 235
7 REGIONAL MARKET ANALYSIS 238
- 7.1 INTRODUCTION 238
- 7.2 NORTH AMERICA 241
- 7.2.1 U.S. 251
- 7.2.2 OTHERS 254
- 7.3 EUROPE 258
- 7.3.1 GERMANY 269
- 7.3.2 FRANCE 272
- 7.3.3 ITALY 275
- 7.3.4 OTHERS 278
- 7.4 ASIA PACIFIC 282
- 7.4.1 INDIA 293
- 7.4.2 CHINA 296
- 7.4.3 JAPAN 299
- 7.4.4 OTHERS 302
- 7.5 REST OF THE WORLD (ROW) 306
- 7.5.1 BRAZIL 316
- 7.5.2 MIDDLE EAST 319
- 7.5.3 OTHERS 322
8 COMPANY DEVELOPMENTS 326
- 8.1 INTRODUCTION 326
- 8.1.1 APPROVAL AS A MAJOR GROWTH STRATEGY OF BLOOD COLLECTION, PROCESSING, MANAGEMENT DEVICES & CONSUMABLES PLAYERS 326
- 8.2 APPROVALS 328
- 8.3 NEW PRODUCT LAUNCH 332
- 8.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 335
- 8.5 OTHER DEVELOPMENTS 337
- 8.6 MERGERS & ACQUISITIONS 338
9 COMPANY PROFILES 339
- 9.1 ABBOTT LABORATORIES, INC 339
- 9.1.1 OVERVIEW 339
- 9.1.2 FINANCIALS 340
- 9.1.3 PRODUCT PORTFOLIO 342
- 9.1.4 KEY DEVELOPMENTS 343
- 9.1.5 BUSINESS STRATEGY 343
- 9.1.6 SWOT ANALYSIS 344
- 9.2 BIO-RAD LABORATORIES 345
- 9.2.1 OVERVIEW 345
- 9.2.2 FINANCIALS 346
- 9.2.3 PRODUCT PORTFOLIO 349
- 9.2.4 KEY DEVELOPMENTS 350
- 9.2.5 BUSINESS STRATEGY 350
- 9.2.6 SWOT ANALYSIS 351
- 9.3 BIOMERIEUX 352
- 9.3.1 OVERVIEW 352
- 9.3.2 FINANCIALS 353
- 9.3.3 PRODUCT PORTFOLIO 356
- 9.3.4 KEY DEVELOPMENTS 357
- 9.3.5 BUSINESS STRATEGY 357
- 9.3.6 SWOT ANALYSIS 358
- 9.4 BECTON DICKINSON AND COMPANY 359
- 9.4.1 OVERVIEW 359
- 9.4.2 FINANCIALS 360
- 9.4.3 PRODUCT PORTFOLIO 363
- 9.4.4 KEY DEVELOPMENTS 365
- 9.4.5 BUSINESS STRATEGY 366
- 9.4.6 SWOT ANALYSIS 367
- 9.5 DANAHER CORPORATION (BECKMAN COULTER) 368
- 9.5.1 OVERVIEW 368
- 9.5.2 FINANCIALS 369
- 9.5.3 PRODUCT PORTFOLIO 371
- 9.5.4 KEY DEVELOPMENTS 373
- 9.5.5 BUSINESS STRATEGY. 373
- 9.5.6 SWOT ANALYSIS 375
- 9.6 FRESENIUS KABI 376
- 9.6.1 OVERVIEW 376
- 9.6.2 FINANCIALS 377
- 9.6.3 PRODUCT PORTFOLIO 380
- 9.6.4 KEY DEVELOPMENTS 382
- 9.6.5 BUSINESS STRATEGY 383
- 9.6.6 SWOT ANALYSIS 384
- 9.7 GRIFOLS INTERNATIONAL SA 385
- 9.7.1 OVERVIEW 385
- 9.7.2 FINANCIALS 386
- 9.7.3 PRODUCT PORTFOLIO 388
- 9.7.4 KEY DEVELOPMENTS 390
- 9.7.5 BUSINESS STRATEGY 391
- 9.7.6 SWOT ANALYSIS 392
- 9.8 HAEMONETICS CORPORATION 393
- 9.8.1 OVERVIEW 393
- 9.8.2 FINANCIALS 394
- 9.8.3 PRODUCT PORTFOLIO 397
- 9.8.4 KEY DEVELOPMENTS 400
- 9.8.5 BUSINESS STRATEGY 400
- 9.8.6 SWOT ANALYSIS 401
- 9.9 IMMUCOR INC 402
- 9.9.1 OVERVIEW 402
- 9.9.2 FINANCIALS 403
- 9.9.3 PRODUCT PORTFOLIO 405
- 9.9.4 KEY DEVELOPMENTS 406
- 9.9.5 BUSINESS STRATEGY 407
- 9.9.6 SWOT ANALYSIS 408
- 9.10 MACOPHARMA 409
- 9.10.1 OVERVIEW 409
- 9.10.2 FINANCIALS 409
- 9.10.3 PRODUCT PORTFOLIO 410
- 9.10.4 KEY DEVELOPMENTS 411
- 9.10.5 BUSINESS STRATEGY 411
- 9.10.6 SWOT ANALYSIS 412
- 9.11 ROCHE DIAGNOSTICS 413
- 9.11.1 OVERVIEW 413
- 9.11.2 FINANCIALS 414
- 9.11.3 PRODUCT PORTFOLIO 415
- 9.11.4 KEY DEVELOPMENTS 416
- 9.11.5 BUSINESS STRATEGY 417
- 9.11.6 SWOT ANALYSIS 418
- 9.12 SYSMEX CORPORATION 419
- 9.12.1 OVERVIEW 419
- 9.12.2 FINANCIALS 420
- 9.12.3 PRODUCT PORTFOLIO 422
- 9.12.4 KEY DEVELOPMENTS 423
- 9.12.5 BUSINESS STRATEGY 423
- 9.12.6 SWOT ANALYSIS 424
- 9.13 TERUMO CORPORATION 425
- 9.13.1 OVERVIEW 425
- 9.13.2 FINANCIALS 426
- 9.13.3 PRODUCT PORTFOLIO 429
- 9.13.4 KEY DEVELOPMENTS 430
- 9.13.5 BUSINESS STRATEGY 431
- 9.13.6 SWOT ANALYSIS 432
- 9.14 THERMO FISHER SCIENTIFIC, INC 433
- 9.14.1 OVERVIEW 433
- 9.14.2 FINANCIALS 434
- 9.14.3 PRODUCT PORTFOLIO 437
- 9.14.4 KEY DEVELOPMENTS 439
- 9.14.5 BUSINESS STRATEGY 439
Summary:
Get latest Market Research Reports on Blood Collection, Processing, Management Devices & Consumables . Industry analysis & Market Report on Blood Collection, Processing, Management Devices & Consumables is a syndicated market report, published as Blood Collection, Processing, Management Devices & Consumables Global Market . It is complete Research Study and Industry Analysis of Blood Collection, Processing, Management Devices & Consumables market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
